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Abstract
Background: Preparation of RNA free from DNA is a critical step before performing RT-PCR
assay. Total RNA isolated from several sources, including those obtained from Saccharomyces
cerevisiae, using routine methodologies are frequently contaminated with DNA, which can give rise
to amplification products that mimic the amplicons expected from the RNA target.
Results: We investigated the efficiency of two DNase I based protocols for eliminating DNA
contaminations from RNA samples obtained from yeast cells. Both procedures are very efficient in
eliminating DNA contamination from RNA samples and entail three main steps, which involve
treating of RNA samples with DNase I, inhibition of the enzyme by EDTA and its subsequent
inactivation at 65°C. The DNase I treated samples were further purified with phenol: chloroform
followed by precipitation with ice-cold ethanol (protocol I) or, alternatively, they were directly
used in RT-PCR reactions (protocol II). Transcripts from ACT1, PDA1, CNA1, CNA2, TPS1 and
TPS2 analyzed after each treatment showed that all mRNAs tested can be amplified if total RNA
was extracted and purified after DNase I treatment, however, only TPS1, TPS2 and ACT1 mRNAs
were amplified without extraction/purification step.
Conclusion: Although more laborious and requiring a higher initial amount of material, the
inclusion of an extraction and purification step allows to prepare RNA samples that are free from
DNA and from low molecular contaminants and can be applied to amplify any Saccharomyces
cerevisiae mRNA by RT-PCR.
Background
The adaptation of polymerase chain reaction (PCR) meth-
odology to the investigation of RNA provides the
researcher a method featuring speed, efficiency, specificity
and sensitivity. Since RNA cannot serve as a template for
DNA polymerase, a reverse transcription step was com-
bined with PCR to transform RNA into a suitable comple-
mentary DNA (cDNA), a technique that is referred to as
RT-PCR (reverse transcriptase – polymerase chain reac-
tion) [1]. RT-PCR has enabled important experiments
dealing with gene expression and its regulation. More sen-
sitive and less laborious than Northern blotting
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hybridization and RNase protection assays, it has rapidly
become a common procedure [2].
However, a frequent cause of concern among investigators
performing quantitative RT-PCR is inaccurate data acqui-
sition due to DNA contamination in RNA preparations,
because PCR cannot discriminate between cDNA targets
synthesized by reverse transcription and genomic DNA
contamination. DNA contamination in RNA preparations
is easily detected by performing a non-reverse tran-
scriptase control. Furthermore, PCR primers can be
designed for controlling the genomic DNA contamina-
tion. Primers that span intron-exon boundaries amplify a
product from contaminating DNA that includes the
intron, making it larger than the expected cDNA product.
Alternatively, primers can be designed to anneal at a splice
junction avoiding any signal based on DNA contamina-
tion [3]. Unfortunately, the genome of low eukaryotic or
prokaryotic cells has few intron containing genes, which
makes the above strategies useless. We have been faced
with the problem of DNA contamination in our samples
of RNA after initial attempts to study mRNA level in Sac-
chromyces cerevisiae by RT-PCR. Common methods used to
remove DNA from RNA samples include poly (A) mRNA
purification by oligo (dT) chromatography [4], selective
RNA precipitation with lithium chloride [5] and selective
DNA extraction with acid phenol: chloroform [6]. Oligo
(dT) chromatography is expensive and requires extensive
manipulation whereas LiCl precipitation and acid phenol:
chloroform extraction could not be effective, mainly in
the amplification of rare transcripts when an increasing
number of cycles or amount of template RNA has to be
used. An alternative method employs treatment of RNA
samples with DNase I followed by heat inactivation of the
enzyme [7]. Optionally, heat denatured DNase is
extracted and RNA precipitated in order to avoid the pres-
ence of some compounds that could interfere with RT-
PCR assay. The present study describes the comparison of
two protocols for preparing yeast RNA free from DNA
suitable for RT-PCR analysis based on DNase I removal of
genomic DNA.
Here, we analyze the use in RT-PCR assay of yeast RNA
samples isolated from routine techniques and treated by
DNase I, in order to remove the DNA contamination. An
additional step of RNA extraction followed by precipita-
tion with ethanol must be included in order to guarantee
that the unfractionated RNA samples are suitable for the
analysis of expression of any Saccharomyces cerevisiae gene.
We hope that the re-evaluation of the methods for prepa-
ration of samples for RT-PCR showed here will encourage
the use of this up to now under appreciated methodology
for analyzing the mRNA levels in Saccharomyces cerevisiae.
Results and discussion
Figure 1 shows the results of RT-PCR experiments using
DNase-treated or untreated total RNA samples amplified
using ACT1 (fig 1A) or CNA1 primers (fig. 1B). Untreated
RNA samples produced the expected 407 bp (ACT1) or
629 bp (CNA1) amplicons, respectively, in the presence of
active (fig. 1A and 1B, lanes 2) or heat inactivated reverse
transcriptase (fig. 1A and 1B, lanes 1). Since RNA cannot
serve as a template for DNA polymerase, these results
make evident that DNA was present as a contaminant in
the crude RNA preparations. Treatment of RNA samples
with DNase I followed by RNA precipitation eliminated
DNA contamination as judged by RT-minus control for
ACT1 (fig. 1A, lane 3) and CNA1 reactions (fig 1B, lane 3).
At the same time, it did not interfere with the production
of ACT1 or CNA1 amplicons (fig. 1A and 1B, lanes 4)
from their respective mRNA. Similar results were found
for ACT1 reactions when DNase I treated samples were
used without following precipitation (protocol II) (fig.
1A, lanes 5 and 6). On the other hand, CNA1 amplicons
were not detected in RT-minus control neither in RT-PCR
reactions using these same RNA-treated samples as tem-
plate (fig. 1B, lanes 5 and 6). Based on these results, it
seems that the use of treated RNA samples without the
DNA contamination in total RNA isolated from Saccharomy- ces cerevisiae Figure 1
DNA contamination in total RNA isolated from Sac-
charomyces cerevisiae. Total RNA was isolated from Sac-
charomyces cerevisiae cells harvested at cellular density of 1.2 
mg (dry weight/mL). PCR and RT-PCR amplicons were gen-
erated by 30 reactions cycles using ACT1 or CNA1 primers 
and 1.0 µg of RNA. Ten micro liters of each reaction was 
electrophoresed on a 1.3% agarose gel and stained with 
ethidium bromide. A – ACT1 amplicons. B – CNA1 ampli-
cons. Untreated total RNA amplified by PCR (lane 1) or RT-
PCR (lane 2); treated samples according to protocol I, fol-
lowed by PCR (lane 3) or RT-PCR amplifications (lane 4); 
treated samples according to protocol II followed by PCR 
(lane 5) or RT-PCR amplification (lane 6).BMC Molecular Biology 2005, 6:9 http://www.biomedcentral.com/1471-2199/6/9
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subsequent extraction/purification step produced an
inhibitory effect on RT-PCR. To further address this ques-
tion, we used a RNA sample treated according to protocol
II as the source of templates to amplify six different
mRNAs. ACT1, TPS1 and TPS2 transcripts generated the
expected amplicons (fig. 2, lanes 3, 4 and 7), whereas
CNA1, PDA1 and CNA2 failed to be amplified by RT-PCR
(fig. 2, lanes 2, 5 and 6). In contrast, all of the six tran-
scripts have been successfully amplified by RT-PCR if RNA
templates were treated with DNase I followed by extrac-
tion/precipitation step with ethanol [8,9]. The compound
that interfered on RT-PCR reaction could be EDTA, which
is added to DNase I reaction in order to inactivate the
enzyme. When carried over to the RT-PCR assay, EDTA
could affect the free Mg2+ concentration in the reaction
mixture, changing the efficiency of amplification in a
primer-template dependent way. To test if the excess of
free EDTA carried over from DNase I treatment, indeed
affects the efficiency of RT-PCR assay, DNase I activity was
stopped by the addition of increasing amounts of EDTA
(ranging from 1.25 to 2.25 mM), before the heat inactiva-
tion of the enzyme. The 629 bp CNA1 amplicons were
detected when the reactions were stopped with 1.5 to 2.0
mM EDTA (resulting in a molar ratio from 0.7 to 1.2 of
EDTA molecule to Mg2+ ions (Fig. 3, lanes 2, 3 and 4). The
addition of EDTA in concentrations out of this range abol-
ished the amplification (Fig. 3, lanes 1 and 5).
To emphasize the fact that a simple DNase I treatment on
crude RNA preparation is sufficient to perform accurate
estimative of mRNA level by RT-PCR, we carried out the
study of the expression of ACT1  mRNA along of the
growth of an yeast strain in YPAD medium, using
untreated and treated RNA samples obtained from cells
harvested at different growth stages (Fig. 4, A and 4B). The
amplification by RT-PCR using ACT1 primers and DNase
I treated samples produced less intense bands (Fig 4B) at
all growth phases when compared to those where
untreated RNA was used (Fig. 4A). At stationary phase,
using total RNA devoid of DNA contamination (Fig. 4B,
lane 6) no expression of ACT1  genes was observed, a
result consistent with those obtained using northern-blot-
ting analysis [10], that showed a 100-fold decrease in
ACT1 mRNA level at stationary phase.
In conclusion, total yeast RNA preparations can be made
suitable for RT-PCR analysis of gene expression if they are
free of contaminant DNA. DNase I treatment was effective
in reducing to an undetectable level the DNA originally
present in RNA samples. Different DNase brands can be
used for this purpose. Here, DNase I preparations sup-
plied form different manufacturers were used and both
were very efficient in eliminating contaminant DNA. An
additional step of extraction of reminiscent RNA with
phenol: chloroform: isoamyl alcohol and precipitation
Primer-template dependent inhibitory effect on mRNA  amplification Figure 2
Primer-template dependent inhibitory effect on 
mRNA amplification. RNA samples extracted from cells 
harvested at 2,1 mg (dry weight)/mL were treated with 
DNase I according to protocol II. Different set of primers (as 
described in table I) was used to amplify CNA2 (lane 2), ACT1 
(lane 3), TPS2 (lane 4), PDA1 (lane 5), CNA1 (lane 6), TPS1 
(lane 7) mRNAs. 100 bp DNA ladder (lane P) and RT-minus 
control using ACT1 primers (lane 1).
Effect of EDTA concentration on CNA1 mRNA amplification  by RT-PCR Figure 3
Effect of EDTA concentration on CNA1 mRNA 
amplification by RT-PCR. RNA samples extracted from 
cells harvested at 1.2 mg (dry weight/mL) were treated with 
DNase I according to protocol II. The reactions were 
stopped by the addition of 1.25 mM (lane 1), 1.5 mM (lane 2), 
1.75 mM (lane 3); 2.0 mM (lane 4) and 2.25 mM (lane 5) of 
EDTA and treated samples were amplified by RT-PCR using 
CNA1 primers. P, 100 bp DNA Ladder (BioLabs-Inc).BMC Molecular Biology 2005, 6:9 http://www.biomedcentral.com/1471-2199/6/9
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with ethanol, as described in Protocol I, although more
laborious, can be applied to amplify any Saccharomyces
cerevisiae  RNA using RT-PCR methodology. The main
problem with this procedure is the need of starting with a
higher amount of RNA to minimize loss of the sample
during the precipitation step. Protocol II, on the other
hand, is simple, practical and rapid because it avoids the
extraction/precipitation steps and allows the direct use of
treated RNA samples for RT-PCR assays. However, as mag-
nesium concentration is a critical parameter in both RT
and PCR reactions, the amount of EDTA used for inhibit-
ing DNase I activity must be carefully titrated.
Conclusion
RT-PCR can be a method for determining transcript level
in total unfractionated yeast RNA, since the RNA samples
are free from contaminant DNA.
DNA contamination from RNA samples can be efficiently
eliminated by treatment with commercial DNase I
preparations.
However, although simple and efficient, that treatment
introduces chelant cation in RNA samples which makes it,
in some cases, not suitable to be utilized in a subsequent
enzymatic analysis like RT-PCR, because the enzymes
used in that methodology, reverse transcriptase and DNA
polimerase are Mg2+-dependent.
To ensure that no false positive result, or on the contrary,
failure on mRNA amplification occur, we established a
general procedure for any S. cerevisiae mRNA
amplification, where an additional step of RNA extraction
followed by precipitation with ethanol was included.
The re-evaluation of these methods described here will
permit, a large scale or repetitive gene expression evalua-
tion as those commonly performed during yeast utiliza-
tion in industry, can be performed by RT-PCR, without
additional cost, since even unfractionated RNA can be
suitable for this methodology.
Methods
Yeast strain, growth conditions and extraction of total 
RNA
Total yeast RNA was isolated by a modification of the pro-
cedure described previously [11]. Strain W303-1A (Mata,
ade2-1, trp1-1, leu2,3-112, his3-11,15, ura3, can1-100) was
grown in YPD-supplemented medium (1% yeast extract,
2% bacto peptone, 2% glucose and 0,01% of adenine,
uracil, tryptophan, leucine and histidine) in a rotatory
shaker (160 rpm and 28°C). Cell growth was monitored
by reading OD at 570 nm. Cells (10 mg of dry weight)
were harvested by centrifugation and washed with DEPC
(diethylpyrocarbonate) treated water at 2200 × g for 5
min before they were resuspended in 0.6 ml RNA extrac-
tion buffer (10 mM EDTA (ethylenediaminetetracetic
acid), 50 mM Tris-HCl pH 7.5, 0.1M NaCl, 5% SDS) and
0.6 ml of phenol:chloroform:isoamyl alcohol (50:50:1)
mixture. After 6 min at room temperature, 2 g of glass
beads (0.45 mm diameter) were added and the cells were
broken by vigorous agitation for 2 min on a vortex mix set
at maximum speed. The extract was transferred to a micro-
fuge tube (1.5 ml) and cell debris and organic phase were
separated from upper aqueous phase by centrifugation at
2200 × g for 5 min (24°C). The upper phase was collected,
extracted twice with 1 volume of phenol: chloroform: iso-
amyl alcohol (50:50:1) and once with 1 volume of chlo-
roform: isoamyl alcohol (24:1). The RNA was precipitated
from the last upper aqueous phase by the addition of 0.1
volume of 3M NaOAc, pH 5.2, plus 3 volumes of ice-cold
absolute ethanol followed by incubation at -20°C for 1 h.
The RNA was pelleted by centrifugation at 15000 × g for
15 min (4°C), washed once with ice-cold 70% ethanol
and again pelleted at 15000 × g for 15 min. After the
remaining alcohol was allowed to evaporate, the pellet
was resuspended in 30 µl of DEPC treated water. Concen-
Abundance of ACT1 transcripts during growth of Saccharo- myces cerevisiae in glucose Figure 4
Abundance of ACT1 transcripts during growth of Sac-
charomyces cerevisiae in glucose. RT-PCR amplicons 
were generated by 30 reactions cycles using ACT1 primers 
and 1.0 µg of RNA. Ten micro liters of each reaction were 
electrophoresed on a 1.3% agarose gel and stained with EtBr. 
Total RNA was isolated from Saccharomyces cerevisiae cells 
grown in YPD-supplemented medium and harvested at 0.7 
mg (dry weight)/ml (lane 1); 1.2 mg (dry weight)/ml (lane 2); 
2.1 mg (dry weight)/ml (lane 3); 2.6 mg (dry weight)/ml (lane 
4); 3.2 mg (dry weight)/ml (lane 5) and 7.0 mg (dry weight)/ml 
(lane 6). P, 123 bp DNA Ladder (BioLabs -Inc). A – 
Untreated RNA; B – RNA treated with Danes I by protocol IBMC Molecular Biology 2005, 6:9 http://www.biomedcentral.com/1471-2199/6/9
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tration of RNA in the sample was measured by reading
OD at 260 nm in a Beckman DU-6 spectrophotometer (1
OD = 42 µg RNA/ml). All materials and solutions were
previously treated with DEPC [12].
Removal of contaminating genomic DNA from 
unfractionated RNA
RNA samples were treated with RNase-free bovine pancre-
atic DNase I (E.C. 3.1.21.1) to eliminate DNA
contamination using two different protocols. Protocol I
was a modification of the procedure previously described
for C. Botulinum [13]. Six micrograms of RNA, 6.25 mM
MgCl2 and 10U of RNase-free DNase I (Sigma) in a 10 µl
reaction mixture in water were incubated at 37°C for 30
min. The reaction was stopped by the addition of 2 mM
EDTA, pH 8.0, followed by incubation at 37°C for 1 min
before inactivation at 65°C for 10 min. RNA was extracted
with 1 volume of phenol: chloroform (5:1) and after cen-
trifugation at 2200 × g for 5 min, the RNA present in the
upper aqueous phase was precipitated with ice-cold abso-
lute ethanol and collected by centrifugation at 15000 × g
for 15 min (4°C). The remaining alcohol was allowed to
evaporate and the pellet was resuspended in 30 µl of
DEPC treated water. Protocol II was performed using the
DNase I amplification grade kit (Life Technologies, Inc.)
following the recommended procedure. In brief, 1 µg of
RNA was resuspended in 20 mM Tris-HCl pH 8.4; 2.0 mM
MgCl2; 50 mM KCl and 1U of DNase I into a final volume
of 10 µl. After incubation for 15 min at room temperature,
DNase was inactivated by the addition of 2,2 mM EDTA,
pH 8.0, and subsequent incubation at 65°C for 10 min.
The product of this reaction was used directly for RT-PCR
without further treatment.
RT-PCR assay
mRNAs were amplified by using the kit Ready-to-Go RT-
PCR Beads (Amershan Pharmacia Biotech Inc.) in a Gene-
Amp PCR System 2400 (Perkin Elmer Inc.). Each reaction
contained ~2.0U of TaqDNA polimerase, 10 mM Tris-HCl
pH 9.0, 60 mM KCl, 1.5 mM MgCl2, 200 µM of each
dNTP, MMuLV reverse transcriptase, RNA guard ribonu-
clease inhibitor, stabilizer including RNase/DNase free
BSA, 1 µg of total RNA and 20 pmol of the appropriate
primers (Del Aguila et al, 2003; Souza, 2001) (Table 1)
into a final volume of 50 µl. Synthesis of cDNA was per-
formed at 50°C for 20 min and stopped by inactivation of
reverse transcriptase at 95°C for 10 min. Amplification of
cDNA by PCR was performed for 30 sec at 95°C; 30 sec at
65°C and 1 min at 72° C for 30 cycles, chosen after testing
amplification from 20 to 40 cycles. RT minus controls was
incubated at 95°C for 10 min to inactivate M-MuLV
(Moloney murine leukemia virus) reverse transcriptase
before cDNA synthesis and PCR steps. RT-PCR products
were run on 1.3% agarose gel in 1x TAE (40 mM Tris-ace-
tate and 1 mM EDTA) buffer, pH.8.0, and stained with
aqueous ethidium bromide at a concentration of 0.5 µg/
mL [12]. Data represent a typical result obtained from
three different experiments.
Abbreviations
DEPC, diethylpyrocarbonate; EDTA, ethylenediamine-
tetraacetic acid; EtBr, ethidium bromide; M-MulV-RT,
moloney murineleukemia virus reverse transcriptase; RT-
PCR, reverse transcriptase – polimerase chain reaction
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Table 1: Oligonucleotides used as primers in RT-PCR analysis
Target mRNA Primer Sequence Amplicon Size (bp)
TPS1 Forward CGCTAAGGCGCAACTGACCTCGTCT
Reverse CGACGAGAATGCGTGGTTGGCATAC
379
TPS2 Forward CCCCCCAAACTATCAGATTGGAACAAC
Reverse ACCCAGCTGCAGCTATTCCATCGGC
612
PDA1 Forward GGTCAGGAGGCCATTGCTGT
Reverse GACCAGCAATTGGATCGTTCTTGG
673
CNA1 Forward CGAAAGACTTGAATTCTTCACGCATC
Reverse GAATGATCTGCAGCAAGCATCG
629
CNA2 Forward CCTTATATCTGTTCCCGCCC
Reverse GAGGAACCATGGTTTTGGAG
551
ACT1 Forward CCTACGTTGGTGATGAAGCT
Reverse GTCAGTCAAATCTCTACCGG
407
CNA1, CNA2, PDA1 and ACT1 primer sequences were obtained from Del Aguila et al, 2003 and TPS1 and TPS2, from Souza, 2001.Publish with BioMed Central    and   every 
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